Tag Archives: Health Bill

Guest Blogspot: The NHS needs outstanding management as well as a legal framework, for example, to unlock the potential of the property portfolio.

The potential for improved efficiency in delivering effective healthcare within the framework of the Health and Social Care Act 2012 is enormous.  However, there will be no benefit without the management skills needed to take up the challenges. Many future … Continue reading

Posted in CCGs, Commissioning, competition, Department of Health, Election, Employment, GPs, Health Bill, Health Team, Healthcare, Hospitals, Information, NHS, Nursing, Uncategorized | Tagged , , , , , , , , , , , , , , , | 2 Comments

The Health and Social Care Bill: Final Stages in Parliament

With opposition to the Health and Social Care Bill having reached new heights, we must look behind the rhetoric and remember basic principles. The most important point to remember is that the NHS exists to provide the best possible, affordable … Continue reading

Posted in Andrew Lansley, Business, Commissioning, competition, David Cameron, Department of Health, GPs, Health Bill, Hospitals, Inequality, NHS, Patient choice, Patients | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest Blogspot: Misleading, Biased Reporting on the Health and Social Care Bill in the Media

Above all the freedom of the Press is paramount. Censorship or severely restrictive legislation is not an acceptable alternative. We sometimes have to accept the consequences and tolerate a Press that can be wrong, unfair, misleading or more interested in … Continue reading

Posted in Andrew Lansley, competition, David Cameron, Department of Health, equality, Finance, Health Bill, Hospitals, Inequality, NHS, Patients, Private | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | 6 Comments

Political Mood Change over the NHS, Innovation and the Pharmaceutical Industry in 2011

As 2011 draws to a close now is a good time to reflect on the period since the last UK General Election in 2010. We must consider what we have done right, what we have done wrong and what remains … Continue reading

Posted in Business, David Cameron, Department of Health, Drugs, Election, Genetics, Health Bill, Health Team, Hospitals, Innovation, NHS, Pharma, Policy, Research | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Commons passes Health and Social Care Bill

The Health and Social Care Bill was passed by the House of Commons yesterday with a government majority of 65.  The bill was delayed earlier this year when it was put on hold due to mounting criticisms of the proposed … Continue reading

Posted in Andrew Lansley, Health Bill | Tagged | Leave a comment

Guest Blogspot – The UK Government’s Latest Thinking on the Value-Based Pricing of Medicines

The UK Government yesterday published its detailed response to the three-month public consultation concluded in March 2011 on value-based pharmaceutical pricing. The Government has emphasised that work on the proposals is still at an early stage. The mistake made with … Continue reading

Posted in Andrew Lansley, Business, Department of Health, Drugs, Employment, Finance, Innovation, NHS, Patients, Pharma, Policy, Research | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest Blogspot: NHS Reforms- What the UK Government Policy Changes Really Mean

There is a strong consensus amongst independent experts, medical professionals and politicians that major NHS reforms are both desirable and inevitable. Healthcare is one of mankind’s greatest priorities. An aging population and medical advances mean that healthcare expenditure is bound … Continue reading

Posted in Andrew Lansley, Business, competition, David Cameron, Department of Health, Drugs, Elderly, GPs, Health Bill, Hospitals, NHS, Policy, Research, White Paper | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment